Verition Fund Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-57,451	Closed	-$436K	–	3516
2025 Q3	$436K	Buy	57,451 +35,555	+162%	+$296K	﹤0.01%	3104
2025 Q2	$196K	Sell	21,896 -47,964	-69%	-$447K	﹤0.01%	3369
2025 Q1	$524K	Buy	69,860 +15,414	+28%	+$124K	﹤0.01%	2565
2024 Q4	$409K	Buy	54,446 +14,926	+38%	+$113K	﹤0.01%	2591
2024 Q3	$300K	Sell	39,520 -102,839	-72%	-$782K	﹤0.01%	2643
2024 Q2	$880K	Buy	+142,359	New	+$786K	0.01%	1748
2024 Q1	–	Sell	-31,510	Closed	-$189K	–	2775
2023 Q4	$189K	Sell	31,510 -17,470	-36%	-$101K	﹤0.01%	2054
2023 Q3	$347K	Buy	48,980 +18,300	+60%	+$131K	﹤0.01%	1640
2023 Q2	$216K	Buy	30,680 +8,400	+38%	+$67.4K	﹤0.01%	1794
2023 Q1	$186K	Buy	+22,280	New	+$214K	﹤0.01%	1787
2022 Q2	–	Sell	-15,513	Closed	-$252K	–	2371
2022 Q1	$252K	Buy	+15,513	New	+$249K	﹤0.01%	2233
2021 Q3	–	Sell	-14,634	Closed	-$231K	–	1907
2021 Q2	$231K	Buy	+14,634	New	+$199K	﹤0.01%	1491
2020 Q4	–	Sell	-541,839	Closed	-$1.86M	–	1104
2020 Q3	$1.86M	Buy	+541,839	New	+$2.32M	0.06%	273